News

2019 June 15th
The investment round co-led by Practica Capital, Koinvesticinis fund and angel investors is the largest investment for medical AI solutions in the Baltic states. It is also one of the largest seed rounds among Baltic startups.
post thumbnail
Oxipit, a medical imaging company, has been awarded an “Intelektas. Bendri mokslo-verslo projektai” EU grant for researching and implementing innovative technologies for improved detection of lung nodules as well as diagnosis of pneumothorax and tuberculosis.
CE certified ChestEye AI imaging suite by Oxipit is now available in 7 European languages. In addition to English, ChestEye interface now supports German, French, Spanish, Hungarian, Dutch, Czech and Lithuanian languages. Addition of multi-lingual support further builds on Oxipit strategy to increase day-to-day productivity of radiology specialists.
AI-based medical imaging startup Oxipit will showcase the ChestEye imaging suite at European Congress of Radiology in Vienna. The suite was recently awarded a CE mark which paves the way for clinical software deployment in 32 European markets.
Leading AI-based medical imaging solutions provider Oxipit received CE certification for ChestEye radiology imaging suite. Oxipit ChestEye provides analysis and preliminary reports for 75 most common radiological findings - the largest scope of diagnosis currently available on the market - with an average area under curve metric of 93%. CE mark ensures that the software complies with medical device regulations and paves the way for commercial deployments in 32 European countries.

Media About Us